Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert van Dam
University of California Los Angeles, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
SOFIE BIOSCIENCES, INC
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Van Dam is the PI and a consultant for the company.
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer
RELEVANCE TO PUBLIC HEALTH There is currently a delay of many years between the time biologists discover a novel cancer biomarker or potential therapeutic target, and the time when this target can be observed in living subjects via whole-body imaging. The goal of this proposal is to address this issue by creating a new high-throughput technology to accelerate the discovery/development of the novel ?tracers? that are needed to enable positron emission tomography (PET) imaging of the biological target. By offering practical, simultaneous production of many candidate tracers, the proposed platform will enable high-throughput in vitro and in vivo screening to rapidly find a molecule with suitable in vivo qualities for pre-clinical or clinical imaging.
Filed on May 10, 2017.
Tell us what you know about Robert van Dam's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Robert van Dam filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert van Dam | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | $350,000 - $399,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | $200,000 - $249,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | $40,000 - $59,999 |
| Robert van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC | $5,000 - $9,999 |
| Robert Michael van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC. | Value cannot be readily determined |
| Robert van Dam | University of California Los Angeles | Conflict of Interest | SOFIE BIOSCIENCES, INC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.